Related Experiment Videos
Tumor markers in testis cancer
1Department of Urology, Cleveland Clinic Foundation, Ohio.
The Urologic Clinics of North America
|February 1, 1993
Summary
Serum markers like human chorionic gonadotropin and alpha-fetoprotein, along with other protein, chromosomal, and molecular markers, aid in diagnosing and managing testicular germ-cell tumors.
Area of Science:
- Oncology
- Biochemistry
- Genetics
Background:
- Testicular germ-cell tumors (GCTs) are a significant health concern.
- Accurate diagnosis and effective management of GCTs rely on reliable biomarkers.
Purpose of the Study:
- To review the established and emerging markers for testicular germ-cell tumors.
- To highlight the utility of these markers in clinical practice.
Main Methods:
- Literature review of established protein, chromosomal, and molecular markers for GCTs.
- Analysis of the role of these markers in diagnosis, staging, prognosis, and treatment monitoring.
Main Results:
- Human chorionic gonadotropin (hCG) and alpha-fetoprotein (AFP) are key serum protein markers.
- Lactate dehydrogenase (LDH) and placental alkaline phosphatase (ALP) are additional protein markers.
- Cytogenetic marker i(12p) and molecular markers (oncogenes, tumor suppressor genes) are also relevant.
Conclusions:
- A comprehensive understanding of various markers is crucial for optimal GCT management.
- These markers are indispensable tools for diagnosis, staging, predicting tumor behavior, and monitoring therapeutic response and recurrence.